Intensive Care Interventions Among Children With Toxicologic Exposures to Cardiovascular Medications.
Journal
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
ISSN: 1529-7535
Titre abrégé: Pediatr Crit Care Med
Pays: United States
ID NLM: 100954653
Informations de publication
Date de publication:
01 11 2023
01 11 2023
Historique:
medline:
3
11
2023
pubmed:
3
5
2023
entrez:
3
5
2023
Statut:
ppublish
Résumé
Interventions requiring a PICU are rare in toxicologic exposures, but cardiovascular medications are high-risk exposures due to their hemodynamic effects. This study aimed to describe prevalence of and risk factors for PICU interventions among children exposed to cardiovascular medications. Secondary analysis of Toxicology Investigators Consortium Core Registry from January 2010 to March 2022. International multicenter research network of 40 sites. Patients 18 years old or younger with acute or acute-on-chronic toxicologic exposure to cardiovascular medications. Patients were excluded if exposed to noncardiovascular medications or if symptoms were documented as unlikely related to exposure. None. Of 1,091 patients in the final analysis, 195 (17.9%) received PICU intervention. One hundred fifty-seven (14.4%) received intensive hemodynamic interventions and 602 (55.2%) received intervention in general. Children less than 2 years old were less likely to receive PICU intervention (odds ratio [OR], 0.42; 95% CI, 0.20-0.86). Exposures to alpha-2 agonists (OR, 2.0; 95% CI, 1.11-3.72) and antiarrhythmics (OR, 4.26; 95% CI, 1.41-12.90) were associated with PICU intervention. In the sensitivity analysis removing atropine from the composite outcome PICU intervention, only exposures to calcium channel antagonists (OR, 2.12; 95% CI, 1.09-4.11) and antiarrhythmics (OR, 4.82; 95% CI, 1.57-14.81) were independently associated with PICU intervention. No independent association was identified between PICU intervention and gender, polypharmacy, intentionality or acuity of exposure, or the other medication classes studied. PICU interventions were uncommon but were associated with exposure to antiarrhythmic medications, calcium channel antagonists, and alpha-2 agonists. As demonstrated via sensitivity analysis, exact associations may depend on institutional definitions of PICU intervention. Children less than 2 years old are less likely to require PICU interventions. In equivocal cases, age and exposure to certain cardiovascular medication classes may be useful to guide appropriate disposition.
Identifiants
pubmed: 37133321
doi: 10.1097/PCC.0000000000003274
pii: 00130478-990000000-00199
doi:
Substances chimiques
Calcium Channel Blockers
0
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
893-900Informations de copyright
Copyright © 2023 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Déclaration de conflit d'intérêts
Dr. Burns is the Pediatric Toxicology Section Editor at UpToDate; she received funding from UpToDate. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Références
Goldstick JE, Cunningham RM, Carter PM: Current causes of death in children and adolescents in the United States. N Engl J Med. 2022; 386:1955–1956
Gummin DD, Mowry JB, Beuhler MC, et al.: 2020 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 38th annual report. Clin Toxicol (Phila). 2021; 59:1282–1501
Carreiro S, Miller S, Wang B, et al.: Clinical predictors of adverse cardiovascular events for acute pediatric drug exposures. Clin Toxicol (Phila). 2020; 58:183–189
Lacroix J, Gaudreault P, Gauthier M: Admission to a pediatric intensive care unit for poisoning: A review of 105 cases. Crit Care Med. 1989; 17:748–750
Fazen LE III, Lovejoy FH Jr, Crone RK: Acute poisoning in a children’s hospital: A 2-year experience. Pediatrics. 1986; 77:144–151
Even KM, Armsby CC, Bateman ST: Poisonings requiring admission to the pediatric intensive care unit: A 5-year review. Clin Toxicol (Phila). 2014; 52:519–524
Patel MM, Travers CD, Stockwell JA, et al.: Analysis of interventions required in 12,021 children with acute intoxications admitted to PICUs. Pediatr Crit Care Med. 2017; 18:e281–e289
Love JS, Karshenas DL, Spyres MB, et al.; Toxicology Investigators Consortium Study Group: The toxicology investigators consortium case registry-the 2021 annual report. J Med Toxicol. 2022; 18:267–296
Hughes AR, Lin A, Hendrickson RG; Toxicology Investigator’s Consortium (ToxIC): Clinical and patient characteristics associated with severe outcome in diphenhydramine toxicity. Clin Toxicol (Phila). 2021; 59:918–925
Campleman SL, Brent J, Pizon AF, et al.; Toxicology Investigators’ Consortium (ToxIC): Drug-specific risk of severe QT prolongation following acute drug overdose. Clin Toxicol (Phila). 2020; 58:1326–1334
Leonard JB, Laudone T, Hines EQ, et al.: Critical care interventions in children aged 6 months to 12 years admitted to the pediatric intensive care unit after unintentional cannabis exposures. Clin Toxicol (Phila). 2022; 60:960–965
Krmpotic K, Lobos AT: Clinical profile of children requiring early unplanned admission to the PICU. Hosp Pediatr. 2013; 3:212–218
Weiner L, Mazzeffi MA, Hines EQ, et al.: Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: A retrospective study of the Extracorporeal Life Support Organizations’ ECMO case registry. Clin Toxicol (Phila). 2020; 58:705–710
Rotella JA, Greene SL, Koutsogiannis Z, et al.: Treatment for beta-blocker poisoning: A systematic review. Clin Toxicol (Phila). 2020; 58:943–983
St-Onge M, Anseeuw K, Cantrell FL, et al.: Experts consensus recommendations for the management of calcium channel blocker poisoning in adults. Crit Care Med. 2017; 45:e306–e315
Ozdemir R, Bayrakci B, Tekşam O, et al.: Thirty-three-year experience on childhood poisoning. Turk J Pediatr. 2012; 54:251–259
Offerman S, Levine M, Gosen J, et al.: Pediatric bupropion ingestions in adolescents vs. younger children-a tale of two populations. J Med Toxicol. 2020; 16:6–11
Lee VR, Connolly M, Calello DP: Pediatric poisoning by ingestion: Developmental overview and synopsis of national trends. Pediatr Ann. 2017; 46:e443–e448
Lee DC, Greene T, Dougherty T, et al.: Fatal nifedipine ingestions in children. J Emerg Med. 2000; 19:359–361
Ranniger C, Roche C: Are one or two dangerous? Calcium channel blocker exposure in toddlers. J Emerg Med. 2007; 33:145–154
Watson CJ, Monuteaux M, Burns MM: Pediatric beta-adrenergic antagonist ingestions reported to the National Poison Data System, 2000-2020. In: North American Congress of Clinical Toxicology (NACCT) abstracts 2021. Clin Toxicol (Phila). 2021; 59:1037–1193
Love JN, Sikka N: Are 1-2 tablets dangerous? Beta-blocker exposure in toddlers. J Emerg Med. 2004; 26:309–314
Smith HL, Branick KA, Free ME, et al.: Analysis of ingestion admissions in a midsized pediatric intensive care unit. J Public Health. 2022; 44:918–925
Fernando SM, Reardon PM, Ball IM, et al.: Outcomes and costs of patients admitted to the intensive care unit due to accidental or intentional poisoning. J Intensive Care Med. 2020; 35:386–393
van Beusekom I, Bakhshi-Raiez F, de Keizer NF, et al.: The healthcare costs of intoxicated patients who survive ICU admission are higher than non-intoxicated ICU patients: A retrospective study combining healthcare insurance data and data from a Dutch national quality registry. BMC Emerg Med. 2019; 19:6
Toce MS, Freiman E, O’Donnell KA, et al.: Clinical effects of pediatric clonidine exposure: A retrospective cohort study at a single tertiary care center. J Emerg Med. 2021; 60:58–66
Lowry JA, Burns M, Calello DP: Pediatric pharmaceutical ingestions. Pediatr Ann. 2017; 46:e459–e465
Xavier J, Haranal MY, Reddy SR, et al.: Amiodarone toxicity: An underdiagnosed entity. Ann Pediatr Cardiol. 2016; 9:199–200
Brumfield E, Bernard KRL, Kabrhel C: Life-threatening flecainide overdose treated with intralipid and extracorporeal membrane oxygenation. Am J Emerg Med. 2015; 33:1840.e3–e5